E
On Wednesday December 10th, 2014 Merck (MRK) reported that it achieved early positive results using KEYTRUDA against patients that had triple-negative breast cancer. Triple-negative breast cancer is an advanced form of breast cancer that is more difficult to treat compared to other forms of breast cancer. This is because Triple-negative breast cancer doesn’t express genes…